Cognitive assessment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM). — CFSMEATLAS
Cognitive assessment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM).
Lange, Gudrun, Lin, Jin-Mann S, Chen, Yang et al. · Frontiers in neuroscience · 2024 · DOI
Quick Summary
This study tested cognitive function (thinking and memory skills) in 261 people with ME/CFS and 165 healthy people using a computer-based screening test. Researchers found that people with ME/CFS process information more slowly than healthy people, but their accuracy was similar. Importantly, a single intense exercise test did not make cognitive problems worse, though the full clinic visit itself did cause some cognitive decline in both groups.
Why It Matters
Cognitive dysfunction is a hallmark and often disabling symptom of ME/CFS, yet objective biomarkers are lacking. This study provides evidence that processing speed deficits are measurable and reproducible in ME/CFS, supporting the development of brief, home-based cognitive screening tools. Understanding whether specific activities worsen cognition helps clinicians and patients make informed decisions about activity management and pacing.
Observed Findings
Information processing speed was significantly slower in ME/CFS patients compared to healthy controls (effect sizes 0.3–0.5, p<0.01) across most assessment timepoints.
No significant difference in accuracy (correctness) of cognitive performance was found between ME/CFS and healthy control groups.
Cognitive decline occurred over the course of the full-day clinic visit in both ME/CFS and healthy control participants, independent of exercise testing.
A single session of intense cycle ergometry exercise did not further impair performance speed on any cognitive screening tasks.
Inferred Conclusions
Information processing speed is a reliable, objective marker of cognitive dysfunction in ME/CFS that can be detected with brief computerized screening.
The cognitive effects of a demanding clinic visit are similar between ME/CFS patients and healthy controls, suggesting non-specific fatigue or attention effects rather than disease-specific exacerbation.
A single acute exercise bout does not acutely worsen processing speed, though longer-term or repeated exercise exposure effects remain unknown.
Remaining Questions
What is the mechanism underlying slowed processing speed in ME/CFS—neuroinflammation, mitochondrial dysfunction, or altered neural efficiency?
How do objectively measured processing speed deficits correlate with patient-reported cognitive symptoms ('brain fog') and functional disability?
What This Study Does Not Prove
This study does not prove that exercise causes long-term cognitive decline in ME/CFS patients, nor does it establish why processing speed is slower—only that the difference exists. The lack of accuracy differences suggests cognition may be preserved but efficiency is compromised, but the study cannot explain the biological mechanism. Additionally, findings from clinic-based testing may not fully represent real-world cognitive function or patient-reported 'brain fog.'